ARTV Artiva Biotherapeutics, Inc.
Nasdaq · SEC CIK 1817241 · EDGAR
- Bought, last 12 months
- $109.18M 12 purchases by 2 insiders
- Sold, last 12 months
- $1.94M 15 sales by 5 insiders
- Filings on record
- 95 since 2024-07-22, latest 2026-09-15 16:44
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | $92.68M | — |
| GC Corp. | 10% | $16.50M | — |
| Aslan Fred | Pres, CEO, Dir | — | $1.38M |
| Banerjee Subhashis | Chief Medical Off | — | $179.5K |
| Horan Christopher | Chief Tech Ops Off | — | $178.7K |
| Bush Jennifer | COO, CLO, Secy, Compliance Off | — | $172.8K |
| Raymon Heather | SVP, Research, Development | — | $27.9K |
| Krishnamohan Neha | CFO | — | — |
| Miralles Gines Diego | Pres, Head of R, D | — | — |
| Huston Thad Allen | CFO | — | — |
Transactions 94
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-15 16:44 | 2026-09-15 | ARTV | Aslan Fred | CEO, Dir | A - Grant | $0.00 | +110.0K | 1.60M | +7% | $0 |
| D | 2026-09-14 20:07 | 2026-09-10 | ARTV | Aslan Fred | CEO, Dir | A - Grant | $0.00 | +45.0K | 1.49M | +3% | $0 |
| D | 2026-09-11 18:37 | 2026-09-09 | ARTV | Miralles Gines Diego | Pres, Head of R, D | A - Grant | $0.00 | +45.0K | 122.5K | +58% | $0 |
| D | 2026-09-11 18:36 | 2026-09-09 | ARTV | Horan Christopher | Chief Tech Ops Off | A - Grant | $0.00 | +40.0K | 323.1K | +14% | $0 |
| D | 2026-09-11 18:36 | 2026-09-09 | ARTV | Bush Jennifer | COO, CLO, Compliance Off | A - Grant | $0.00 | +45.0K | 374.5K | +14% | $0 |
| D | 2026-09-11 18:35 | 2026-09-09 | ARTV | Banerjee Subhashis | Chief Medical Off | A - Grant | $0.00 | +30.0K | 170.9K | +21% | $0 |
| T | 2026-09-09 16:02 | 2026-09-08 | ARTV | Aslan Fred | CEO, Dir | S - Sale | $10.92 | -23.4K | 1.45M | -2% | -$255.7K |
| 2026-09-04 16:04 | 2026-09-03 | ARTV | Horan Christopher | Chief Tech Ops Off | S - Sale | $11.16 | -10.4K | 283.1K | -4% | -$115.6K | |
| 2026-09-04 16:03 | 2026-09-03 | ARTV | Bush Jennifer | COO, CLO, Compliance Off | S - Sale | $11.16 | -8,391 | 329.5K | -2% | -$93.6K | |
| 2026-09-04 16:03 | 2026-09-03 | ARTV | Banerjee Subhashis | Chief Medical Off | S - Sale | $11.16 | -1,100 | 140.9K | -0.8% | -$12.3K | |
| 2026-09-04 16:02 | 2026-09-03 | ARTV | Aslan Fred | CEO, Dir | S - Sale | $11.16 | -61.9K | 1.47M | -4% | -$690.4K | |
| DT | 2026-08-31 19:06 | 2026-08-27 | ARTV | Banerjee Subhashis | Chief Medical Off | M - OptEx | $1.92 | +5,306 | 150.3K | +4% | +$10.2K |
| DT | 2026-08-31 19:06 | 2026-08-27 | ARTV | Banerjee Subhashis | Chief Medical Off | S - Sale+OE | $12.01 | -8,222 | 142.0K | -5% | -$98.7K |
| DT | 2026-08-19 21:00 | 2026-08-18 | ARTV | Banerjee Subhashis | Chief Medical Off | M - OptEx | $1.92 | +429 | 145.4K | +0.3% | +$823.68 |
| DT | 2026-08-19 21:00 | 2026-08-18 | ARTV | Banerjee Subhashis | Chief Medical Off | S - Sale+OE | $12.00 | -429 | 145.0K | -0.3% | -$5,148 |
| MI | 2026-07-31 17:13 | 2026-07-29+ | ARTV | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | P - Purchase | $9.96 | +45.8K | 17.33M | +0.3% | +$455.7K |
| I | 2026-07-28 17:24 | 2026-07-24 | ARTV | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | P - Purchase | $9.99 | +41.3K | 17.28M | +0.2% | +$412.8K |
| MI | 2026-07-23 21:22 | 2026-07-21+ | ARTV | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | P - Purchase | $9.76 | +264.6K | 17.24M | +2% | +$2.58M |
| AI | 2026-07-23 21:21 | 2026-07-13 | ARTV | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | P - Purchase | $8.94 | +6,522 | 16.82M | +0.0% | +$58.3K |
| MI | 2026-07-20 18:08 | 2026-07-16+ | ARTV | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | P - Purchase | $8.93 | +160.4K | 16.98M | +1.0% | +$1.43M |
| MI | 2026-07-14 19:00 | 2026-07-10+ | ARTV | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | P - Purchase | $8.96 | +21.7K | 16.82M | +0.1% | +$194.0K |
| MI | 2026-06-29 16:20 | 2026-06-25+ | ARTV | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | P - Purchase | $8.89 | +32.9K | 16.80M | +0.2% | +$292.1K |
| MI | 2026-06-16 18:08 | 2026-06-12+ | ARTV | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | P - Purchase | $8.66 | +531.3K | 16.76M | +3% | +$4.60M |
| MI | 2026-06-11 19:36 | 2026-06-09+ | ARTV | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | P - Purchase | $7.44 | +1.03M | 16.23M | +7% | +$7.65M |
| 2026-05-28 16:34 | 2026-05-11 | ARTV | GC Corp. | 10% | P - Purchase | $11.52 | +1.09M | 4.39M | +33% | +$12.50M | |
| I | 2026-05-28 16:34 | 2026-05-11 | ARTV | GC Corp. | 10% | P - Purchase | $11.52 | +347.2K | 1.61M | +28% | +$4.00M |
| 2026-05-19 21:52 | 2026-05-19 | ARTV | Raymon Heather | SVP, Research, Development | S - Sale | $9.01 | -3,095 | 148.2K | -2% | -$27.9K | |
| 2026-05-19 21:52 | 2026-05-19 | ARTV | Horan Christopher | Chief Tech Ops Off | S - Sale | $9.01 | -7,002 | 293.4K | -2% | -$63.1K | |
| 2026-05-19 21:51 | 2026-05-19 | ARTV | Bush Jennifer | COO, CLO, Compliance Off | S - Sale | $9.01 | -8,790 | 337.9K | -3% | -$79.2K | |
| 2026-05-19 21:50 | 2026-05-19 | ARTV | Banerjee Subhashis | Chief Medical Off | S - Sale | $9.01 | -7,037 | 145.0K | -5% | -$63.4K | |
| 2026-05-19 21:50 | 2026-05-19 | ARTV | Aslan Fred | CEO, Dir | S - Sale | $9.01 | -27.1K | 1.54M | -2% | -$244.3K | |
| D | 2026-05-19 08:11 | 2026-05-18 | ARTV | Miralles Gines Diego | Pres, Head of R, D | A - Grant | $0.00 | +77.5K | 77.5K | New | $0 |
| DI | 2026-05-13 17:45 | 2026-05-11 | ARTV | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | P - Purchase | $11.52 | +6.51M | 15.20M | +75% | +$75.00M |
| 2026-03-10 | 2026-03-10 | ARTV | Huston Thad Allen | CFO | A - Grant | $0.00 | +220.0K | 220.0K | New | $0 | |
| 2026-02-18 | 2026-02-15 | ARTV | Raymon Heather | SVP, Research, Development | A - Grant | $0.00 | +46.0K | 152.8K | +43% | $0 | |
| 2026-02-18 | 2026-02-15 | ARTV | Raymon Heather | SVP, Research, Development | F - Tax | $4.00 | -1,521 | 151.3K | -1.0% | -$6,084 | |
| 2026-02-18 | 2026-02-15 | ARTV | Aslan Fred | Pres, CEO, Dir | F - Tax | $4.00 | -14.6K | 1.56M | -0.9% | -$58.4K | |
| 2026-02-18 | 2026-02-15 | ARTV | Aslan Fred | Pres, CEO, Dir | A - Grant | $0.00 | +366.9K | 1.58M | +30% | $0 | |
| 2026-02-18 | 2026-02-15 | ARTV | Horan Christopher | Chief Tech Ops Off | F - Tax | $4.00 | -2,187 | 300.5K | -0.7% | -$8,748 | |
| 2026-02-18 | 2026-02-15 | ARTV | Horan Christopher | Chief Tech Ops Off | A - Grant | $0.00 | +117.3K | 302.6K | +63% | $0 | |
| 2026-02-18 | 2026-02-15 | ARTV | Bush Jennifer | COO, CLO, Secy, Compliance Off | A - Grant | $0.00 | +117.3K | 350.2K | +50% | $0 | |
| 2026-02-18 | 2026-02-15 | ARTV | Bush Jennifer | COO, CLO, Secy, Compliance Off | F - Tax | $4.00 | -3,515 | 346.7K | -1% | -$14.1K | |
| 2026-02-18 | 2026-02-15 | ARTV | Banerjee Subhashis | Chief Medical Off | A - Grant | $0.00 | +102.0K | 152.0K | +204% | $0 | |
| T | 2025-12-15 | 2025-12-15 | ARTV | Aslan Fred | Pres, CEO, Dir | S - Sale | $6.00 | -3,187 | 1.21M | -0.3% | -$19.1K |
| D | 2025-12-12 | 2025-12-12 | ARTV | Horan Christopher | Chief Tech Ops Off | A - Grant | $0.00 | +107.2K | 185.3K | +137% | $0 |
| D | 2025-12-12 | 2025-12-12 | ARTV | Raymon Heather | SVP, Research, Development | A - Grant | $0.00 | +67.3K | 106.8K | +170% | $0 |
| D | 2025-12-12 | 2025-12-12 | ARTV | Bush Jennifer | COO, CLO, Secy, Compliance Off | A - Grant | $0.00 | +84.9K | 232.9K | +57% | $0 |
| D | 2025-12-12 | 2025-12-12 | ARTV | Aslan Fred | Pres, CEO, Dir | A - Grant | $0.00 | +869.1K | 1.21M | +253% | $0 |
| 2025-11-17 | 2025-11-15 | ARTV | Bush Jennifer | COO, CLO, Secy, Compliance Off | F - Tax | $3.25 | -3,055 | 148.0K | -2% | -$9,929 | |
| 2025-11-17 | 2025-11-15 | ARTV | Horan Christopher | Chief Tech Ops Off | F - Tax | $3.25 | -1,899 | 78.2K | -2% | -$6,172 | |
| 2025-11-17 | 2025-11-15 | ARTV | Krishnamohan Neha | CFO | F - Tax | $3.25 | -3,490 | 99.4K | -3% | -$11.3K | |
| 2025-11-17 | 2025-11-15 | ARTV | Raymon Heather | SVP, Research, Development | F - Tax | $3.25 | -1,375 | 39.6K | -3% | -$4,469 | |
| T | 2025-11-17 | 2025-11-15 | ARTV | Aslan Fred | Pres, CEO, Dir | F - Tax | $3.25 | -6,347 | 350.4K | -2% | -$20.6K |
| T | 2025-11-17 | 2025-11-17 | ARTV | Aslan Fred | Pres, CEO, Dir | S - Sale | $3.38 | -6,375 | 344.0K | -2% | -$21.5K |
| 2025-10-17 | 2025-10-17 | ARTV | Aslan Fred | Pres, CEO, Dir | S - Sale | $6.00 | -25.5K | 356.7K | -7% | -$153.0K | |
| M | 2025-08-18 | 2025-05-15+ | ARTV | Horan Christopher | Chief Tech Ops Off | F - Tax | $2.58 | -4,918 | 83.7K | -6% | -$12.7K |
| M | 2025-08-18 | 2025-05-15+ | ARTV | Bush Jennifer | COO, CLO, Secy, Compliance Off | F - Tax | $2.61 | -8,346 | 151.1K | -5% | -$21.8K |
| M | 2025-08-18 | 2025-05-15+ | ARTV | Raymon Heather | SVP, Research, Development | F - Tax | $2.56 | -2,384 | 41.0K | -5% | -$6,094 |
| M | 2025-08-18 | 2025-05-15+ | ARTV | Krishnamohan Neha | CFO | F - Tax | $2.63 | -7,154 | 102.8K | -7% | -$18.8K |
| M | 2025-08-18 | 2025-05-15+ | ARTV | Aslan Fred | Pres, CEO, Dir | F - Tax | $2.44 | -8,944 | 382.2K | -2% | -$21.8K |
| 2025-08-18 | 2025-08-15 | ARTV | Aslan Fred | Pres, CEO, Dir | S - Sale | $2.73 | -25.5K | 386.7K | -6% | -$69.6K | |
| D | 2025-04-25 | 2025-04-08 | ARTV | Banerjee Subhashis | Chief Medical Off | A - Grant | $0.00 | +50.0K | 50.0K | New | $0 |
| 2025-03-07 | 2025-03-05 | ARTV | Aslan Fred | Pres, CEO, Dir | A - Grant | $0.00 | +200.0K | 416.7K | +92% | $0 | |
| 2025-02-28 | 2025-02-26 | ARTV | Raymon Heather | SVP, Research, Development | A - Grant | $0.00 | +33.4K | 43.4K | +334% | $0 | |
| 2025-02-28 | 2025-02-26 | ARTV | Bush Jennifer | COO, CLO, Secy, Compliance Off | A - Grant | $0.00 | +86.7K | 159.4K | +119% | $0 | |
| 2025-02-28 | 2025-02-26 | ARTV | Graef Thorsten | Chief Medical Off | A - Grant | $0.00 | +60.0K | 80.0K | +300% | $0 | |
| 2025-02-28 | 2025-02-26 | ARTV | Horan Christopher | Chief Tech Ops Off | A - Grant | $0.00 | +60.0K | 85.0K | +240% | $0 | |
| 2025-02-28 | 2025-02-26 | ARTV | Krishnamohan Neha | CFO | A - Grant | $0.00 | +60.0K | 110.0K | +120% | $0 | |
| 2024-09-13 | 2024-09-12 | ARTV | Horan Christopher | Chief Tech Ops Off | A - Grant | $0.00 | +25.0K | 25.0K | New | $0 | |
| 2024-09-13 | 2024-09-12 | ARTV | Bush Jennifer | COO, CLO, Secy, Compliance Off | A - Grant | $0.00 | +50.0K | 72.8K | +219% | $0 | |
| 2024-09-13 | 2024-09-12 | ARTV | Graef Thorsten | Chief Medical Off | A - Grant | $0.00 | +20.0K | 20.0K | New | $0 | |
| 2024-09-13 | 2024-09-12 | ARTV | Krishnamohan Neha | CFO | A - Grant | $0.00 | +50.0K | 50.0K | New | $0 | |
| 2024-09-13 | 2024-09-12 | ARTV | Raymon Heather | SVP, Research, Development | A - Grant | $0.00 | +10.0K | 10.0K | New | $0 | |
| DMI | 2024-07-24 | 2024-07-22 | ARTV | 5AM Partners VI, LLC | 10% | J - Other | $10.20 | +461.7K | 1.17M | +65% | +$4.71M |
| DI | 2024-07-24 | 2024-07-22 | ARTV | 5AM Partners VI, LLC | 10% | C - Cnv Deriv | — | +1.06M | 1.06M | New | — |
| DI | 2024-07-24 | 2024-07-22 | ARTV | 5AM Partners VI, LLC | 10% | P - Purchase | $12.00 | +833.3K | 1.18M | +239% | +$10.00M |
| DMI | 2024-07-24 | 2024-07-22 | ARTV | Kolchinsky Peter | Dir, 10% | C - Cnv Deriv | — | +1.06M | 725.4K | New | — |
| DMI | 2024-07-24 | 2024-07-22 | ARTV | Kolchinsky Peter | Dir, 10% | J - Other | $10.20 | +461.7K | 1.05M | +79% | +$4.71M |
| DMI | 2024-07-24 | 2024-07-22 | ARTV | Kolchinsky Peter | Dir, 10% | P - Purchase | $12.00 | +8.33M | 826.8K | New | +$100.00M |
| D | 2024-07-22 | 2024-07-22 | ARTV | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 10% | J - Other | $10.20 | +49.0K | 194.1K | +34% | +$500.0K |
| D | 2024-07-22 | 2024-07-22 | ARTV | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 10% | C - Cnv Deriv | — | +145.1K | 145.1K | New | — |
| DMI | 2024-07-22 | 2024-07-22 | ARTV | Huh Yong-Jun | Dir | J - Other | $10.20 | +550.4K | 1.64M | +51% | +$5.61M |
| DMI | 2024-07-22 | 2024-07-22 | ARTV | Huh Yong-Jun | Dir | P - Purchase | $12.00 | +2.08M | 3.31M | +170% | +$25.00M |
| DMI | 2024-07-22 | 2024-07-22 | ARTV | Huh Yong-Jun | Dir | C - Cnv Deriv | — | +1.35M | 587.5K | New | — |
| DM | 2024-07-22 | 2024-07-22 | ARTV | VENBIO GLOBAL STRATEGIC GP III, LTD | 10% | C - Cnv Deriv | — | +1.06M | 1.06M | New | — |
| D | 2024-07-22 | 2024-07-22 | ARTV | VENBIO GLOBAL STRATEGIC GP III, LTD | 10% | J - Other | — | +461.7K | 1.52M | +44% | — |
| D | 2024-07-22 | 2024-07-22 | ARTV | VENBIO GLOBAL STRATEGIC GP III, LTD | 10% | P - Purchase | $12.00 | +416.7K | 1.94M | +27% | +$5.00M |
| D | 2024-07-22 | 2024-07-22 | ARTV | Aslan Fred | Pres, CEO, Dir | A - Grant | $0.00 | +228.9K | 228.9K | New | $0 |
| DI | 2024-07-22 | 2024-07-22 | ARTV | GC Cell Corp | 10% | P - Purchase | $12.00 | +416.7K | 1.26M | +49% | +$5.00M |
| DI | 2024-07-22 | 2024-07-22 | ARTV | GC Cell Corp | 10% | J - Other | $10.20 | +256.3K | 843.8K | +44% | +$2.61M |
| DMI | 2024-07-22 | 2024-07-22 | ARTV | GC Cell Corp | 10% | C - Cnv Deriv | — | +355.0K | 525.3K | +208% | — |
| D | 2024-07-22 | 2024-07-22 | ARTV | GC Cell Corp | 10% | P - Purchase | $12.00 | +1.67M | 3.31M | +102% | +$20.00M |
| D | 2024-07-22 | 2024-07-22 | ARTV | GC Cell Corp | 10% | J - Other | $10.20 | +294.1K | 1.64M | +22% | +$3.00M |
| DM | 2024-07-22 | 2024-07-22 | ARTV | GC Cell Corp | 10% | C - Cnv Deriv | — | +997.3K | 1.02M | +5,321% | — |
Purchase Sale Sale after option exercise All abbreviations